Nations Financial Group’s Anixa Biosciences ANIX Stock Holding History

Nations Financial Group’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$63K	Hold	22,500	–	–	﹤0.01%	784
2026 Q1	$58K	Hold	22,500	–	–	﹤0.01%	766
2025 Q4	$70.2K	Hold	22,500	–	–	﹤0.01%	741
2025 Q3	$74.3K	Hold	22,500	–	–	﹤0.01%	704
2025 Q2	$74.3K	Hold	22,500	–	–	0.01%	674
2025 Q1	$64.3K	Hold	22,500	–	–	﹤0.01%	649
2024 Q4	$52.2K	Hold	22,500	–	–	﹤0.01%	661
2024 Q3	$70.9K	Hold	22,500	–	–	0.01%	662
2024 Q2	$49.7K	Buy	22,500 +7,500	+50%	+$21.3K	﹤0.01%	624
2024 Q1	$46.8K	Hold	15,000	–	–	﹤0.01%	616
2023 Q4	$58.2K	Hold	15,000	–	–	0.01%	611
2023 Q3	$49K	Hold	15,000	–	–	﹤0.01%	605
2023 Q2	$48K	Buy	15,000 +3,500	+30%	+$13.5K	﹤0.01%	606
2023 Q1	$49.5K	Sell	11,500 -1,500	-12%	-$6.57K	0.01%	607
2022 Q4	$55.3K	Buy	+13,000	New	+$62.5K	0.01%	588

Other funds holding ANIX

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LNWTC

Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Nations Financial Group's ANIX Position: Q2 2026 in Review

Nations Financial Group held its Anixa Biosciences (ANIX) position steady in Q2 2026 at 22,500 shares worth $63K. The position accounts for ﹤0.01% of the portfolio, ranked #784.

Nations Financial Group first reported a position in ANIX in Q4 2022 and has held it in 15 quarters since. The position peaked at $74.3K in Q3 2025. 62 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

Nations Financial Group held 22,500 shares of Anixa Biosciences worth $63K as of Q2 2026.
Nations Financial Group left its Anixa Biosciences share count unchanged in Q2 2026.
Anixa Biosciences made up ﹤0.01% of Nations Financial Group's portfolio in Q2 2026, its #784 holding.
Nations Financial Group first reported a position in Anixa Biosciences in Q4 2022 and has held it in 15 quarters since.
Nations Financial Group's Anixa Biosciences position peaked at $74.3K in Q3 2025.
62 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on Nations Financial Group's 13F filing for Q2 2026, filed 23 Jul 2026.